PAUL FURINO: Open Payments
NPI 1902065931 · ARCADIA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,593 in 26 payments from 10 companies in 2025. Trend: 2023 $889 · 2024 $680 · 2025 $1,593
Food & beverage: $1,593
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $702 |
| ABBVIE INC. | 2 | $242 |
| Otsuka America Pharmaceutical, Inc. | 2 | $240 |
| Alkermes, Inc. | 4 | $146 |
| Janssen Pharmaceuticals, Inc | 1 | $115 |
| Supernus Pharmaceuticals, Inc. | 2 | $47 |
| Tris Pharma Inc | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
Products named: CAPLYTA, VRAYLAR, ABILIFY MAINTENA, SPRAVATO, REXULTI, LYBALVI, Qelbree, Dyanavel XR.
Industry payments across FL — which companies pay providers there.
